0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Eye Drug - Global Market Insights and Sales Trends 2024
Published Date: November 2023
|
Report Code: QYRE-Auto-5L7052
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Eye Drug Market Insights and Forecast to 2028
BUY CHAPTERS

Eye Drug - Global Market Insights and Sales Trends 2024

Code: QYRE-Auto-5L7052
Report
November 2023
Pages:112
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Eye Drug - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Eye Drug -  Market

Eye Drug - Market

The global Eye Drug market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Eye Drug in various end use industries. The expanding demands from the Glaucoma, Retinal Disease, Bacterial?Infection and Other, are propelling Eye Drug market. Drops, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Tablet & Capsule segment is estimated at % CAGR for the next seven-year period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Eye Drug, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Eye Drug market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Eye Drug market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Eye Drug sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Eye Drug covered in this report include Pfizer, Novartis, bausch Lomb, Laboratoire Riva, Jamp Pharma, Fresenius, Teva Pharmaceutical?, SANDOZ and Greenstone, etc.
The global Eye Drug market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Novartis
bausch Lomb
Laboratoire Riva
Jamp Pharma
Fresenius
Teva Pharmaceutical?
SANDOZ
Greenstone
Mylan
GE Medical
Mint Pharmaceuticals
Laboratoires Thea
Taj Pharmaceuticals
Actavis
APOTEX
Sun Pharma

Scope of Eye Drug - Market Report

Report Metric Details
Report Name Eye Drug - Market
CAGR 5%
Global Eye Drug market, by region:
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Eye Drug market, Segment by Type:
  • Drops
  • Tablet & Capsule
Global Eye Drug market, by Application
  • Glaucoma
  • Retinal Disease
  • Bacterial?Infection
  • Other
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
  • Chapter Two: Detailed analysis of Eye Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter Three: Sales, revenue of Eye Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
  • Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
  • Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
  • Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter Twelve: Analysis of sales channel, distributors and customers.
  • Chapter Thirteen: Research Findings and Conclusion.

FAQ for this report

What are the Application segmentation covered in the Eye Drug - Market report?

Ans: The Applications covered in the Eye Drug - Market report are Glaucoma, Retinal Disease, Bacterial?Infection, Other

What are the Type segmentation covered in the Eye Drug - Market report?

Ans: The Types covered in the Eye Drug - Market report are Drops, Tablet & Capsule

1 Eye Drug Market Overview
1.1 Eye Drug Product Overview
1.2 Eye Drug Market Segment by Type
1.2.1 Drops
1.2.2 Tablet & Capsule
1.3 Global Eye Drug Market Size by Type
1.3.1 Global Eye Drug Market Size Overview by Type (2018-2029)
1.3.2 Global Eye Drug Historic Market Size Review by Type (2018-2023)
1.3.3 Global Eye Drug Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Eye Drug Sales Breakdown by Type (2018-2023)
1.4.2 Europe Eye Drug Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Eye Drug Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Eye Drug Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Eye Drug Sales Breakdown by Type (2018-2023)
2 Global Eye Drug Market Competition by Company
2.1 Global Top Players by Eye Drug Sales (2018-2023)
2.2 Global Top Players by Eye Drug Revenue (2018-2023)
2.3 Global Top Players by Eye Drug Price (2018-2023)
2.4 Global Top Manufacturers Eye Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Eye Drug Market Competitive Situation and Trends
2.5.1 Eye Drug Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Eye Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Eye Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Eye Drug Market
2.8 Key Manufacturers Eye Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Eye Drug Status and Outlook by Region
3.1 Global Eye Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Eye Drug Historic Market Size by Region
3.2.1 Global Eye Drug Sales in Volume by Region (2018-2023)
3.2.2 Global Eye Drug Sales in Value by Region (2018-2023)
3.2.3 Global Eye Drug Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Eye Drug Forecasted Market Size by Region
3.3.1 Global Eye Drug Sales in Volume by Region (2024-2029)
3.3.2 Global Eye Drug Sales in Value by Region (2024-2029)
3.3.3 Global Eye Drug Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Eye Drug by Application
4.1 Eye Drug Market Segment by Application
4.1.1 Glaucoma
4.1.2 Retinal Disease
4.1.3 Bacterial?Infection
4.1.4 Other
4.2 Global Eye Drug Market Size by Application
4.2.1 Global Eye Drug Market Size Overview by Application (2018-2029)
4.2.2 Global Eye Drug Historic Market Size Review by Application (2018-2023)
4.2.3 Global Eye Drug Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Eye Drug Sales Breakdown by Application (2018-2023)
4.3.2 Europe Eye Drug Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Eye Drug Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Eye Drug Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Eye Drug Sales Breakdown by Application (2018-2023)
5 North America Eye Drug by Country
5.1 North America Eye Drug Historic Market Size by Country
5.1.1 North America Eye Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Eye Drug Sales in Volume by Country (2018-2023)
5.1.3 North America Eye Drug Sales in Value by Country (2018-2023)
5.2 North America Eye Drug Forecasted Market Size by Country
5.2.1 North America Eye Drug Sales in Volume by Country (2024-2029)
5.2.2 North America Eye Drug Sales in Value by Country (2024-2029)
6 Europe Eye Drug by Country
6.1 Europe Eye Drug Historic Market Size by Country
6.1.1 Europe Eye Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Eye Drug Sales in Volume by Country (2018-2023)
6.1.3 Europe Eye Drug Sales in Value by Country (2018-2023)
6.2 Europe Eye Drug Forecasted Market Size by Country
6.2.1 Europe Eye Drug Sales in Volume by Country (2024-2029)
6.2.2 Europe Eye Drug Sales in Value by Country (2024-2029)
7 Asia-Pacific Eye Drug by Region
7.1 Asia-Pacific Eye Drug Historic Market Size by Region
7.1.1 Asia-Pacific Eye Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Eye Drug Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Eye Drug Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Eye Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Eye Drug Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Eye Drug Sales in Value by Region (2024-2029)
8 Latin America Eye Drug by Country
8.1 Latin America Eye Drug Historic Market Size by Country
8.1.1 Latin America Eye Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Eye Drug Sales in Volume by Country (2018-2023)
8.1.3 Latin America Eye Drug Sales in Value by Country (2018-2023)
8.2 Latin America Eye Drug Forecasted Market Size by Country
8.2.1 Latin America Eye Drug Sales in Volume by Country (2024-2029)
8.2.2 Latin America Eye Drug Sales in Value by Country (2024-2029)
9 Middle East and Africa Eye Drug by Country
9.1 Middle East and Africa Eye Drug Historic Market Size by Country
9.1.1 Middle East and Africa Eye Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Eye Drug Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Eye Drug Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Eye Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Eye Drug Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Eye Drug Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Eye Drug Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Pfizer Eye Drug Products Offered
10.1.5 Pfizer Recent Development
10.2 Novartis
10.2.1 Novartis Company Information
10.2.2 Novartis Introduction and Business Overview
10.2.3 Novartis Eye Drug Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Novartis Eye Drug Products Offered
10.2.5 Novartis Recent Development
10.3 bausch Lomb
10.3.1 bausch Lomb Company Information
10.3.2 bausch Lomb Introduction and Business Overview
10.3.3 bausch Lomb Eye Drug Sales, Revenue and Gross Margin (2018-2023)
10.3.4 bausch Lomb Eye Drug Products Offered
10.3.5 bausch Lomb Recent Development
10.4 Laboratoire Riva
10.4.1 Laboratoire Riva Company Information
10.4.2 Laboratoire Riva Introduction and Business Overview
10.4.3 Laboratoire Riva Eye Drug Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Laboratoire Riva Eye Drug Products Offered
10.4.5 Laboratoire Riva Recent Development
10.5 Jamp Pharma
10.5.1 Jamp Pharma Company Information
10.5.2 Jamp Pharma Introduction and Business Overview
10.5.3 Jamp Pharma Eye Drug Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Jamp Pharma Eye Drug Products Offered
10.5.5 Jamp Pharma Recent Development
10.6 Fresenius
10.6.1 Fresenius Company Information
10.6.2 Fresenius Introduction and Business Overview
10.6.3 Fresenius Eye Drug Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Fresenius Eye Drug Products Offered
10.6.5 Fresenius Recent Development
10.7 Teva Pharmaceutical?
10.7.1 Teva Pharmaceutical? Company Information
10.7.2 Teva Pharmaceutical? Introduction and Business Overview
10.7.3 Teva Pharmaceutical? Eye Drug Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Teva Pharmaceutical? Eye Drug Products Offered
10.7.5 Teva Pharmaceutical? Recent Development
10.8 SANDOZ
10.8.1 SANDOZ Company Information
10.8.2 SANDOZ Introduction and Business Overview
10.8.3 SANDOZ Eye Drug Sales, Revenue and Gross Margin (2018-2023)
10.8.4 SANDOZ Eye Drug Products Offered
10.8.5 SANDOZ Recent Development
10.9 Greenstone
10.9.1 Greenstone Company Information
10.9.2 Greenstone Introduction and Business Overview
10.9.3 Greenstone Eye Drug Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Greenstone Eye Drug Products Offered
10.9.5 Greenstone Recent Development
10.10 Mylan
10.10.1 Mylan Company Information
10.10.2 Mylan Introduction and Business Overview
10.10.3 Mylan Eye Drug Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Mylan Eye Drug Products Offered
10.10.5 Mylan Recent Development
10.11 GE Medical
10.11.1 GE Medical Company Information
10.11.2 GE Medical Introduction and Business Overview
10.11.3 GE Medical Eye Drug Sales, Revenue and Gross Margin (2018-2023)
10.11.4 GE Medical Eye Drug Products Offered
10.11.5 GE Medical Recent Development
10.12 Mint Pharmaceuticals
10.12.1 Mint Pharmaceuticals Company Information
10.12.2 Mint Pharmaceuticals Introduction and Business Overview
10.12.3 Mint Pharmaceuticals Eye Drug Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Mint Pharmaceuticals Eye Drug Products Offered
10.12.5 Mint Pharmaceuticals Recent Development
10.13 Laboratoires Thea
10.13.1 Laboratoires Thea Company Information
10.13.2 Laboratoires Thea Introduction and Business Overview
10.13.3 Laboratoires Thea Eye Drug Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Laboratoires Thea Eye Drug Products Offered
10.13.5 Laboratoires Thea Recent Development
10.14 Taj Pharmaceuticals
10.14.1 Taj Pharmaceuticals Company Information
10.14.2 Taj Pharmaceuticals Introduction and Business Overview
10.14.3 Taj Pharmaceuticals Eye Drug Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Taj Pharmaceuticals Eye Drug Products Offered
10.14.5 Taj Pharmaceuticals Recent Development
10.15 Actavis
10.15.1 Actavis Company Information
10.15.2 Actavis Introduction and Business Overview
10.15.3 Actavis Eye Drug Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Actavis Eye Drug Products Offered
10.15.5 Actavis Recent Development
10.16 APOTEX
10.16.1 APOTEX Company Information
10.16.2 APOTEX Introduction and Business Overview
10.16.3 APOTEX Eye Drug Sales, Revenue and Gross Margin (2018-2023)
10.16.4 APOTEX Eye Drug Products Offered
10.16.5 APOTEX Recent Development
10.17 Sun Pharma
10.17.1 Sun Pharma Company Information
10.17.2 Sun Pharma Introduction and Business Overview
10.17.3 Sun Pharma Eye Drug Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Sun Pharma Eye Drug Products Offered
10.17.5 Sun Pharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Eye Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Eye Drug Industrial Chain Analysis
11.4 Eye Drug Market Dynamics
11.4.1 Eye Drug Industry Trends
11.4.2 Eye Drug Market Drivers
11.4.3 Eye Drug Market Challenges
11.4.4 Eye Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Eye Drug Distributors
12.3 Eye Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
    Table 1. Major Company of Drops
    Table 2. Major Company of Tablet & Capsule
    Table 3. Global Eye Drug Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
    Table 4. Global Eye Drug Sales by Type (2018-2023) & (MT)
    Table 5. Global Eye Drug Sales Market Share in Volume by Type (2018-2023)
    Table 6. Global Eye Drug Sales by Type (2018-2023) & (US& Million)
    Table 7. Global Eye Drug Market Share in Value by Type (2018-2023)
    Table 8. Global Eye Drug Price by Type (2018-2023) & (USD/Kg)
    Table 9. Global Eye Drug Sales by Type (2024-2029) & (MT)
    Table 10. Global Eye Drug Sales Market Share in Volume by Type (2024-2029)
    Table 11. Global Eye Drug Sales by Type (2024-2029) & (US$ Million)
    Table 12. Global Eye Drug Sales Market Share in Value by Type (2024-2029)
    Table 13. Global Eye Drug Price by Type (2024-2029) & (USD/Kg)
    Table 14. North America Eye Drug Sales by Type (2018-2023) & (MT)
    Table 15. North America Eye Drug Sales by Type (2018-2023) & (US$ Million)
    Table 16. Europe Eye Drug Sales (MT) by Type (2018-2023)
    Table 17. Europe Eye Drug Sales by Type (2018-2023) & (US$ Million)
    Table 18. Asia-Pacific Eye Drug Sales (MT) by Type (2018-2023)
    Table 19. Asia-Pacific Eye Drug Sales by Type (2018-2023) & (US$ Million)
    Table 20. Latin America Eye Drug Sales (MT) by Type (2018-2023)
    Table 21. Latin America Eye Drug Sales by Type (2018-2023) & (US$ Million)
    Table 22. Middle East and Africa Eye Drug Sales (MT) by Type (2018-2023)
    Table 23. Middle East and Africa Eye Drug Sales by Type (2018-2023) & (US$ Million)
    Table 24. Global Eye Drug Sales by Company (2018-2023) & (MT)
    Table 25. Global Eye Drug Sales Share by Company (2018-2023)
    Table 26. Global Eye Drug Revenue by Company (2018-2023) & (US$ Million)
    Table 27. Global Eye Drug Revenue Share by Company (2018-2023)
    Table 28. Global Market Eye Drug Price by Company (2018-2023) & (USD/Kg)
    Table 29. Global Eye Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
    Table 30. Global Eye Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Eye Drug as of 2022)
    Table 32. Date of Key Manufacturers Enter into Eye Drug Market
    Table 33. Key Manufacturers Eye Drug Product Type
    Table 34. Mergers & Acquisitions, Expansion Plans
    Table 35. Global Eye Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 36. Global Eye Drug Sales by Region (2018-2023) & (MT)
    Table 37. Global Eye Drug Sales Market Share in Volume by Region (2018-2023)
    Table 38. Global Eye Drug Sales by Region (2018-2023) & (US$ Million)
    Table 39. Global Eye Drug Sales Market Share in Value by Region (2018-2023)
    Table 40. Global Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
    Table 41. Global Eye Drug Sales by Region (2024-2029) & (MT)
    Table 42. Global Eye Drug Sales Market Share in Volume by Region (2024-2029)
    Table 43. Global Eye Drug Sales by Region (2024-2029) & (US$ Million)
    Table 44. Global Eye Drug Sales Market Share in Value by Region (2024-2029)
    Table 45. Global Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2024-2029)
    Table 46. Global Eye Drug Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 47. Global Eye Drug Sales by Application (2018-2023) & (MT)
    Table 48. Global Eye Drug Sales Market Share in Volume by Application (2018-2023)
    Table 49. Global Eye Drug Sales by Application (2018-2023) & (US$ Million)
    Table 50. Global Eye Drug Sales Market Share in Value by Application (2018-2023)
    Table 51. Global Eye Drug Price by Application (2018-2023) & (USD/Kg)
    Table 52. Global Eye Drug Sales by Application (2024-2029) & (MT)
    Table 53. Global Eye Drug Sales Market Share in Volume by Application (2024-2029)
    Table 54. Global Eye Drug Sales by Application (2024-2029) & (US$ Million)
    Table 55. Global Eye Drug Sales Market Share in Value by Application (2024-2029)
    Table 56. Global Eye Drug Price by Application (2024-2029) & (USD/Kg)
    Table 57. North America Eye Drug Sales by Application (2018-2023) (MT)
    Table 58. North America Eye Drug Sales by Application (2018-2023) & (US$ Million)
    Table 59. Europe Eye Drug Sales by Application (2018-2023) (MT)
    Table 60. Europe Eye Drug Sales by Application (2018-2023) & (US$ Million)
    Table 61. Asia-Pacific Eye Drug Sales by Application (2018-2023) (MT)
    Table 62. Asia-Pacific Eye Drug Sales by Application (2018-2023) & (US$ Million)
    Table 63. Latin America Eye Drug Sales by Application (2018-2023) (MT)
    Table 64. Latin America Eye Drug Sales by Application (2018-2023) & (US$ Million)
    Table 65. Middle East and Africa Eye Drug Sales by Application (2018-2023) (MT)
    Table 66. Middle East and Africa Eye Drug Sales by Application (2018-2023) & (US$ Million)
    Table 67. North America Eye Drug Sales by Country (2018-2023) & (MT)
    Table 68. North America Eye Drug Sales Market Share in Volume by Country (2018-2023)
    Table 69. North America Eye Drug Sales by Country (2018-2023) & (US$ Million)
    Table 70. North America Eye Drug Sales Market Share in Value by Country (2018-2023)
    Table 71. North America Eye Drug Sales by Country (2024-2029) & (MT)
    Table 72. North America Eye Drug Sales Market Share in Volume by Country (2024-2029)
    Table 73. North America Eye Drug Sales by Country (2024-2029) & (US$ Million)
    Table 74. North America Eye Drug Sales Market Share in Value by Country (2024-2029)
    Table 75. Europe Eye Drug Sales by Country (2018-2023) & (MT)
    Table 76. Europe Eye Drug Sales Market Share in Volume by Country (2018-2023)
    Table 77. Europe Eye Drug Sales by Country (2018-2023) & (US$ Million)
    Table 78. Europe Eye Drug Sales Market Share in Value by Country (2018-2023)
    Table 79. Europe Eye Drug Sales by Country (2024-2029) & (MT)
    Table 80. Europe Eye Drug Sales Market Share in Volume by Country (2024-2029)
    Table 81. Europe Eye Drug Sales by Country (2024-2029) & (US$ Million)
    Table 82. Europe Eye Drug Sales Market Share in Value by Country (2024-2029)
    Table 83. Asia-Pacific Eye Drug Sales by Region (2018-2023) & (MT)
    Table 84. Asia-Pacific Eye Drug Sales Market Share in Volume by Region (2018-2023)
    Table 85. Asia-Pacific Eye Drug Sales by Region (2018-2023) & (US$ Million)
    Table 86. Asia-Pacific Eye Drug Sales Market Share in Value by Region (2018-2023)
    Table 87. Asia-Pacific Eye Drug Sales by Region (2024-2029) & (MT)
    Table 88. Asia-Pacific Eye Drug Sales Market Share in Volume by Region (2024-2029)
    Table 89. Asia-Pacific Eye Drug Sales by Region (2024-2029) & (US$ Million)
    Table 90. Asia-Pacific Eye Drug Sales Market Share in Value by Region (2024-2029)
    Table 91. Latin America Eye Drug Sales by Country (2018-2023) & (MT)
    Table 92. Latin America Eye Drug Sales Market Share in Volume by Country (2018-2023)
    Table 93. Latin America Eye Drug Sales by Country (2018-2023) & (US$ Million)
    Table 94. Latin America Eye Drug Sales Market Share in Value by Country (2018-2023)
    Table 95. Latin America Eye Drug Sales by Country (2024-2029) & (MT)
    Table 96. Latin America Eye Drug Sales Market Share in Volume by Country (2024-2029)
    Table 97. Latin America Eye Drug Sales by Country (2024-2029) & (US$ Million)
    Table 98. Latin America Eye Drug Sales Market Share in Value by Country (2024-2029)
    Table 99. Middle East and Africa Eye Drug Sales by Country (2018-2023) & (MT)
    Table 100. Middle East and Africa Eye Drug Sales Market Share in Volume by Country (2018-2023)
    Table 101. Middle East and Africa Eye Drug Sales by Country (2018-2023) & (US$ Million)
    Table 102. Middle East and Africa Eye Drug Sales Market Share in Value by Country (2018-2023)
    Table 103. Middle East and Africa Eye Drug Sales by Country (2024-2029) & (MT)
    Table 104. Middle East and Africa Eye Drug Sales Market Share in Volume by Country (2024-2029)
    Table 105. Middle East and Africa Eye Drug Sales by Country (2024-2029) & (US$ Million)
    Table 106. Middle East and Africa Eye Drug Sales Market Share in Value by Country (2024-2029)
    Table 107. Pfizer Company Information
    Table 108. Pfizer Introduction and Business Overview
    Table 109. Pfizer Eye Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2023)
    Table 110. Pfizer Eye Drug Product
    Table 111. Pfizer Recent Development
    Table 112. Novartis Company Information
    Table 113. Novartis Introduction and Business Overview
    Table 114. Novartis Eye Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2023)
    Table 115. Novartis Eye Drug Product
    Table 116. Novartis Recent Development
    Table 117. bausch Lomb Company Information
    Table 118. bausch Lomb Introduction and Business Overview
    Table 119. bausch Lomb Eye Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2023)
    Table 120. bausch Lomb Eye Drug Product
    Table 121. bausch Lomb Recent Development
    Table 122. Laboratoire Riva Company Information
    Table 123. Laboratoire Riva Introduction and Business Overview
    Table 124. Laboratoire Riva Eye Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2023)
    Table 125. Laboratoire Riva Eye Drug Product
    Table 126. Laboratoire Riva Recent Development
    Table 127. Jamp Pharma Company Information
    Table 128. Jamp Pharma Introduction and Business Overview
    Table 129. Jamp Pharma Eye Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2023)
    Table 130. Jamp Pharma Eye Drug Product
    Table 131. Jamp Pharma Recent Development
    Table 132. Fresenius Company Information
    Table 133. Fresenius Introduction and Business Overview
    Table 134. Fresenius Eye Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2023)
    Table 135. Fresenius Eye Drug Product
    Table 136. Fresenius Recent Development
    Table 137. Teva Pharmaceutical? Company Information
    Table 138. Teva Pharmaceutical? Introduction and Business Overview
    Table 139. Teva Pharmaceutical? Eye Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2023)
    Table 140. Teva Pharmaceutical? Eye Drug Product
    Table 141. Teva Pharmaceutical? Recent Development
    Table 142. SANDOZ Company Information
    Table 143. SANDOZ Introduction and Business Overview
    Table 144. SANDOZ Eye Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2023)
    Table 145. SANDOZ Eye Drug Product
    Table 146. SANDOZ Recent Development
    Table 147. Greenstone Company Information
    Table 148. Greenstone Introduction and Business Overview
    Table 149. Greenstone Eye Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2023)
    Table 150. Greenstone Eye Drug Product
    Table 151. Greenstone Recent Development
    Table 152. Mylan Company Information
    Table 153. Mylan Introduction and Business Overview
    Table 154. Mylan Eye Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2023)
    Table 155. Mylan Eye Drug Product
    Table 156. Mylan Recent Development
    Table 157. GE Medical Company Information
    Table 158. GE Medical Introduction and Business Overview
    Table 159. GE Medical Eye Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2023)
    Table 160. GE Medical Eye Drug Product
    Table 161. GE Medical Recent Development
    Table 162. Mint Pharmaceuticals Company Information
    Table 163. Mint Pharmaceuticals Introduction and Business Overview
    Table 164. Mint Pharmaceuticals Eye Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2023)
    Table 165. Mint Pharmaceuticals Eye Drug Product
    Table 166. Mint Pharmaceuticals Recent Development
    Table 167. Laboratoires Thea Company Information
    Table 168. Laboratoires Thea Introduction and Business Overview
    Table 169. Laboratoires Thea Eye Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2023)
    Table 170. Laboratoires Thea Eye Drug Product
    Table 171. Laboratoires Thea Recent Development
    Table 172. Taj Pharmaceuticals Company Information
    Table 173. Taj Pharmaceuticals Introduction and Business Overview
    Table 174. Taj Pharmaceuticals Eye Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2023)
    Table 175. Taj Pharmaceuticals Eye Drug Product
    Table 176. Taj Pharmaceuticals Recent Development
    Table 177. Actavis Company Information
    Table 178. Actavis Introduction and Business Overview
    Table 179. Actavis Eye Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2023)
    Table 180. Actavis Eye Drug Product
    Table 181. Actavis Recent Development
    Table 182. APOTEX Company Information
    Table 183. APOTEX Introduction and Business Overview
    Table 184. APOTEX Eye Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2023)
    Table 185. APOTEX Eye Drug Product
    Table 186. APOTEX Recent Development
    Table 187. Sun Pharma Company Information
    Table 188. Sun Pharma Introduction and Business Overview
    Table 189. Sun Pharma Eye Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2023)
    Table 190. Sun Pharma Eye Drug Product
    Table 191. Sun Pharma Recent Development
    Table 192. Key Raw Materials Lists
    Table 193. Raw Materials Key Suppliers Lists
    Table 194. Eye Drug Market Trends
    Table 195. Eye Drug Market Drivers
    Table 196. Eye Drug Market Challenges
    Table 197. Eye Drug Market Restraints
    Table 198. Eye Drug Distributors List
    Table 199. Eye Drug Downstream Customers
    Table 200. Research Programs/Design for This Report
    Table 201. Key Data Information from Secondary Sources
    Table 202. Key Data Information from Primary Sources
List of Figures
    Figure 1. Eye Drug Product Picture
    Figure 2. Global Eye Drug Market Size, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 3. Global Eye Drug Market Size Status and Outlook (2018-2029) & (US$ Million)
    Figure 4. Global Eye Drug Sales Status and Outlook (2018-2029) & (MT)
    Figure 5. Product Picture of Drops
    Figure 6. Global Drops Sales YoY Growth (2018-2029) & (MT)
    Figure 7. Product Picture of Tablet & Capsule
    Figure 8. Global Tablet & Capsule Sales YoY Growth (2018-2029) & (MT)
    Figure 9. Global Eye Drug Sales by Type (2018-2029) & (US$ Million)
    Figure 10. Global Eye Drug Sales Market Share by Type in 2022 & 2029
    Figure 11. North America Eye Drug Sales Market Share in Volume by Type in 2022
    Figure 12. North America Eye Drug Sales Market Share in Value by Type in 2022
    Figure 13. Europe Eye Drug Sales Market Share in Volume by Type in 2022
    Figure 14. Europe Eye Drug Sales Market Share in Value by Type in 2022
    Figure 15. Asia-Pacific Eye Drug Sales Market Share in Volume by Type in 2022
    Figure 16. Asia-Pacific Eye Drug Sales Market Share in Value by Type in 2022
    Figure 17. Latin America Eye Drug Sales Market Share in Volume by Type in 2022
    Figure 18. Latin America Eye Drug Sales Market Share in Value by Type in 2022
    Figure 19. Middle East and Africa Eye Drug Sales Market Share in Volume by Type in 2022
    Figure 20. Middle East and Africa Eye Drug Sales Market Share in Value by Type in 2022
    Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Eye Drug Sales in 2022
    Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Eye Drug Revenue in 2022
    Figure 23. Eye Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
    Figure 24. Product Picture of Glaucoma
    Figure 25. Global Glaucoma Sales YoY Growth (2018-2029) & (MT)
    Figure 26. Product Picture of Retinal Disease
    Figure 27. Global Retinal Disease Sales YoY Growth (2018-2029) & (MT)
    Figure 28. Product Picture of Bacterial?Infection
    Figure 29. Global Bacterial?Infection Sales YoY Growth (2018-2029) & (MT)
    Figure 30. Product Picture of Other
    Figure 31. Global Other Sales YoY Growth (2018-2029) & (MT)
    Figure 32. Global Eye Drug Sales by Application (2018-2029) & (US$ Million)
    Figure 33. Global Eye Drug Sales Market Share by Application in 2022 & 2029
    Figure 34. North America Eye Drug Sales Market Share in Volume by Application in 2022
    Figure 35. North America Eye Drug Sales Market Share in Value by Application in 2022
    Figure 36. Europe Eye Drug Sales Market Share in Volume by Application in 2022
    Figure 37. Europe Eye Drug Sales Market Share in Value by Application in 2022
    Figure 38. Asia-Pacific Eye Drug Sales Market Share in Volume by Application in 2022
    Figure 39. Asia-Pacific Eye Drug Sales Market Share in Value by Application in 2022
    Figure 40. Latin America Eye Drug Sales Market Share in Volume by Application in 2022
    Figure 41. Latin America Eye Drug Sales Market Share in Value by Application in 2022
    Figure 42. Middle East and Africa Eye Drug Sales Market Share in Value by Application in 2022
    Figure 43. Key Raw Materials Price
    Figure 44. Eye Drug Manufacturing Cost Structure
    Figure 45. Eye Drug Industrial Chain Analysis
    Figure 46. Channels of Distribution
    Figure 47. Distributors Profiles
    Figure 48. Bottom-up and Top-down Approaches for This Report
    Figure 49. Data Triangulation
    Figure 50. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3350

This license allows only one user to access the PDF.
Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS